share_log

榮昌生物：2023年A股股票激勵計劃項下首次授予限制性股票

REMEGEN: THE FIRST GRANT OF THE RESTRICTED SHARES UNDER THE 2023 A SHARE INCENTIVE SCHEME

Hong Kong Stock Exchange ·  Dec 29, 2023 06:52
Summary by Moomoo AI
荣昌生物製藥（煙台）股份有限公司（「荣昌生物」）宣布，其2023年A股股票激勵計劃下首次授予限制性股票的條件已獲滿足，並於2023年12月28日向24名激勵對象授予共1,432,450股限制性股票。每股授予價格為人民幣49.77元，而當日A股收市價為人民幣60.74元。該激勵計劃旨在進一步完善公司治理結構，建立健全激勵約束機制，增強管理團隊及核心員工對公司持續健康發展的責任感。限制性股票將根據業績考核要求分四期歸屬，有效期不得超過84個月。此次授予對象包括高級管理人員及其他員工，並有特定業績考核目標。獨立非執行董事及監事會均同意此次授予，並認為符合相關法律法規及公司章程規定。
荣昌生物製藥（煙台）股份有限公司（「荣昌生物」）宣布，其2023年A股股票激勵計劃下首次授予限制性股票的條件已獲滿足，並於2023年12月28日向24名激勵對象授予共1,432,450股限制性股票。每股授予價格為人民幣49.77元，而當日A股收市價為人民幣60.74元。該激勵計劃旨在進一步完善公司治理結構，建立健全激勵約束機制，增強管理團隊及核心員工對公司持續健康發展的責任感。限制性股票將根據業績考核要求分四期歸屬，有效期不得超過84個月。此次授予對象包括高級管理人員及其他員工，並有特定業績考核目標。獨立非執行董事及監事會均同意此次授予，並認為符合相關法律法規及公司章程規定。
RONG CHANG BIOPHARMACEUTICAL (YANTAI) CO., LTD. (“RONG CHANG BIO”) ANNOUNCED THAT THE CONDITIONS FOR THE FIRST GRANT OF RESTRICTED SHARES UNDER ITS 2023 A-SHARE INCENTIVE PROGRAM HAVE BEEN MET AND A TOTAL OF 1,432,450 SHARES OF RESTRICTED SHARES HAVE BEEN GRANTED TO 24 INCENTIVES ON DECEMBER 28, 2023. The award price per share was RMB49.77, while the A-share closing price was RMB60.74 on the day. The incentive program aims to further improve the corporate governance structure, establish a healthy incentive constraint mechanism, and strengthen the management team and core employees' sense of responsibility for the company's continued healthy development. Restricted shares will be classified in four periods in accordance with the performance review requirements with a validity period of no more than 84 months. This award includes senior management and other staff and has specific performance assessment objectives. The Independent Non-Executive Directors and the Board of Supervisors agree to this award and consider it to be in compliance with the relevant laws and regulations and the Company's Articles of Association.
RONG CHANG BIOPHARMACEUTICAL (YANTAI) CO., LTD. (“RONG CHANG BIO”) ANNOUNCED THAT THE CONDITIONS FOR THE FIRST GRANT OF RESTRICTED SHARES UNDER ITS 2023 A-SHARE INCENTIVE PROGRAM HAVE BEEN MET AND A TOTAL OF 1,432,450 SHARES OF RESTRICTED SHARES HAVE BEEN GRANTED TO 24 INCENTIVES ON DECEMBER 28, 2023. The award price per share was RMB49.77, while the A-share closing price was RMB60.74 on the day. The incentive program aims to further improve the corporate governance structure, establish a healthy incentive constraint mechanism, and strengthen the management team and core employees' sense of responsibility for the company's continued healthy development. Restricted shares will be classified in four periods in accordance with the performance review requirements with a validity period of no more than 84 months. This award includes senior management and other staff and has specific performance assessment objectives. The Independent Non-Executive Directors and the Board of Supervisors agree to this award and consider it to be in compliance with the relevant laws and regulations and the Company's Articles of Association.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more